中国药企出海势头不减,现在人才不够用了 | 海斌访谈

第一财经
Sep 20

中国创新药出海,勾勒出陡峭的上升曲线。  2025年,中国创新药企的势头不减,他们通过海外授权、自建海外基地、NewCo等各种形式开辟中国之外的市场。这一过程中,一些短板和不足,也显露出来了。  过去十年间,中国制药行业培养了大量的人才,但结构性问题突出。在近日举行的2025 Veeva中国研发及质量峰会上,一家知名药企的高层一针见血指出:一到国际多中心临床试验阶段,瞬间就能发现人才的短缺。  ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10